Position in IOVA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,185,176
+$1,069,520 QoQ
Shares Held
337,657
+1683.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WINTON GROUP Ltd holds $82,877,062 across 71 Biotechnology names. IOVA ranks #18 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
173,032 | $16,285,771 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,778 | $11,418,073 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
106,532 | $7,999,487 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
47,925 | $3,558,910 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,080 | $3,453,516 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
367,883 | $3,296,231 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
307,096 | $2,892,844 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
69,291 | $2,787,576 |
All Filings in IOVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,185,176 | 337,657 | Shares | Sole | 2026-05-12 | |
| 2023-03-31 | $115,656 | 18,929 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $119,627 | 18,721 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $170,926 | 17,842 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $269,563 | 16,190 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $250,098 | 13,101 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $708,249 | 15,264 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $604,575 | 18,365 | Shares | Sole | 2020-10-30 | |
| No filing history on record for this holder in this stock. | ||||||